Evid Invest
Holders — by stockHoldings — by fund

KVP Capital Advisors, LP

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001858198

$124.3M

disclosed book value

36

positions

10.1%

largest position share

Positions, as of 2026-09-30

top 36 of 36 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1PRAXPRAXIS PRECISION MEDICINES I42,900$12.5M10.1%
2WHWKWHITEHAWK THERAPEUTICS INC2.2M$8.1M6.6%
3SLNSILENCE THERAPEUTICS PLC684,123$7.5M6%
4PTGXPROTAGONIST THERAPEUTICS INC53,000$7.5M6%
5MBXMBX BIOSCIENCES INC121,524$7.1M5.7%
6ERASERASCA INC455,000$6.7M5.4%
7TRVITREVI THERAPEUTICS INC414,000$5.9M4.8%
8TNGXTANGO THERAPEUTICS INC230,264$5.7M4.6%
9EWTXEDGEWISE THERAPEUTICS INC133,000$5.4M4.3%
10TNDMTANDEM DIABETES CARE INC301,000$4.9M3.9%
11ACHVACHIEVE LIFE SCIENCES INC462,355$3.7M3%
12STROSUTRO BIOPHARMA INC226,575$3.7M2.9%
13INSMINSMED INC28,497$3.3M2.6%
14SVRASAVARA INC605,280$3.1M2.5%
15AVBPARRIVENT BIOPHARMA INC102,000$3.1M2.5%
16IDYAIDEAYA BIOSCIENCES INC79,700$3.1M2.5%
17IRONDISC MEDICINE INC43,750$2.9M2.3%
18UTHRUNITED THERAPEUTICS CORP DEL4,750$2.6M2.1%
19VRDNVIRIDIAN THERAPEUTICS INC125,000$2.6M2.1%
20IMMXIMMIX BIOPHARMA INC230,423$2.4M1.9%
21DSGNDESIGN THERAPEUTICS INC185,000$2.3M1.9%
22OCULOCULAR THERAPEUTIX INC300,000$2.3M1.9%
23TVTXTRAVERE THERAPEUTICS INC39,000$2.3M1.8%
24MLYSMINERALYS THERAPEUTICS INC84,168$2.1M1.7%
25VOGXVOGENX INC86,069$2.0M1.6%
26NKTRNEKTAR THERAPEUTICS26,900$1.6M1.3%
27DRUGBRIGHT MINDS BIOSCIENCES INC31,813$1.6M1.3%
28ZURAZURA BIO LTD373,128$1.6M1.2%
29ARTVARTIVA BIOTHERAPEUTICS INC200,000$1.4M1.1%
30EOLSEVOLUS INC150,000$1.2M1%
31VERAVERA THERAPEUTICS INC32,700$1.1M0.8%
32CABACABALETTA BIO INC505,431$970,4280.8%
33ADILADIAL PHARMACEUTICALS INC210,256$843,1270.7%
34CMPXCOMPASS THERAPEUTICS INC771,000$801,8400.6%
35CELCCELCUITY INC4,000$318,0800.3%
36YARWYARROW BIOSCIENCE INC10,011$225,4470.2%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.